LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

Verastem Inc

Closed

7.55 -4.19

Overview

Share price change

24h

Current

Min

7.47

Max

7.98

Key metrics

By Trading Economics

Income

-41M

-65M

Profit margin

-82.56

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+90.54% upside

Dividends

By Dow Jones

Next Earnings

6 sie 2025

Verastem Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 maj 2025, 19:14 UTC

Major Market Movers

Verastem Ovarian-Cancer Drug Combination Gets FDA Approval -- Update

31 gru 2024, 19:15 UTC

Major Market Movers

Verastem Shares Soar on FDA Priority Review of Cancer Treatment

Peer Comparison

Price change

Verastem Inc Forecast

Price Target

By TipRanks

90.54% upside

12 Months Forecast

Average 15.11 USD  90.54%

High 20 USD

Low 10 USD

Based on 9 Wall Street analysts offering 12 month price targets forVerastem Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

9

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Verastem Inc

There is no Profile data available for 2VS.SG.